Related Experiment Video
Updated: Jun 5, 2025

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
Published on: November 14, 2014
SiO2/Si interferometers designed for on-site botulinum neurotoxin serotypes B and C quantification and biological
D Nanda Kumar1, Zina Baider2, Shlomo E Blum2
1Institute of Agricultural Engineering, ARO, Volcani Institute, Rishon LeZion, 7505101, Israel.
Abstract:
Botulinum neurotoxins (BoNT), the agent causing botulism, exhibit the highest potency among bacterial toxins and pose a significant threat to both humans and animals. The current in vivo method (mouse lethality assay, MLA) is inappropriate for real-time and pen-side assessment of the occurring outbreak or case. Herein, we describe a reflective-based biosensor capable of detecting the toxin's type and activity state by competitive immunoassay and endopeptidase activity, respectively. Two serotypes (BoNT-B and BoNT-C) were assessed independently by SiO2/Si interferometers using simulating antigens or specific peptides (i.e., synaptosomal-associated protein and vesicle-associated membrane protein). The reflective responses of both platforms were biochemically amplified using 4-chloro-1-naphthol oxidation into insoluble products. The resulting refractive index variations were observed in real-time using reflective interferometric Fourier transform spectroscopy. The portable bioassay depicted high sensitivity, selectivity, and near real-time rapid assessment (0.14 and 0.47 pg mL-1 for BoNT-C and BoNT-B, negligible interferences with interfering serotypes, respectively). Additionally, the applicability of the bioassay for monitoring extracted toxins was tested against the in vivo method with satisfactory performance values. Overall, the presented approach can improve field assessment of new botulism incidences by acquiring epidemiological data in near real-time, thus eliminating the need for the MLA approach.
More Related Videos
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013